GIP Antikörper

Produktnummer ABIN5662356

Der Maus Monoklonal Anti-GIP-Antikörper wurde für WB, IHC, IP und ICC validiert. Er ist geeignet, GIP in Proben von Diverse Spezies zu detektieren.

Kurzübersicht für GIP Antikörper (ABIN5662356)

Target: GIP (Gastric Inhibitory Polypeptide (GIP))

Reaktivität: Diverse Spezies

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser GIP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Klon: A2

Produktdetails anti-GIP Antikörper

Verwendungszweck: Monoclonal Antibody to Gastric Inhibitory Polypeptide (GIP)

Spezifität: The antibody is a mouse monoclonal antibody raised against GIP. It has been selected for its ability to recognize GIP in immunohistochemical staining and western blotting.

Kreuzreaktivität: Diverse Spezies

Aufreinigung: Protein A + Protein G affinity chromatography

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.01-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu GIP

Target: GIP (Gastric Inhibitory Polypeptide (GIP))

Andere Bezeichnung: Gastric Inhibitory Polypeptide

Hintergrund: Incretin hormone, Glucose Dependent Insulinotropic Peptide

Pathways: Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism